Heidelberg Pharma AG
XMUN:HPHA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Heidelberg Pharma AG
XMUN:HPHA
|
DE |
|
H
|
Heidelberg Pharma AG
F:HPHA
|
DE |
|
M
|
Metacon AB (publ)
F:M16
|
SE |
|
Dufry AG
OTC:DFRYF
|
CH |
|
A
|
Archer-Daniels-Midland Co
DUS:ADM
|
US |
|
Fortress Biotech Inc
NASDAQ:FBIO
|
US |
|
T
|
Takeda Pharmaceutical Co Ltd
DUS:TKD
|
JP |
|
Akzo Nobel NV
F:AKUP
|
NL |
|
Galderma Group AG
F:PY30
|
CH |
|
A
|
Atoss Software AG
XMUN:AOF
|
DE |
|
Promotora y Operadora de Infraestructura SAB de CV
F:AKY
|
MX |
|
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
|
US |
|
V
|
Vale SA
F:CVLC
|
BR |
|
A
|
Avient Corp
XMUN:PY9
|
US |
|
Liontrust Asset Management PLC
LSE:LIO
|
UK |
|
T
|
TC Energy Corp
XMUN:TRS
|
CA |
|
T
|
Taylor Morrison Home Corp
F:THM
|
US |
|
D
|
Danaher Corp
XMUN:DAP
|
US |
|
T
|
Talanx AG
XMUN:TLX
|
DE |
|
F
|
Fanuc Corp
XMUN:FUC
|
JP |
Bankruptcy Probability
Heidelberg Pharma AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Heidelberg Pharma AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
Heidelberg Pharma AG
XETRA:HPHA
|
124m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
441.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
196.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
167.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
126.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
70.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Heidelberg Pharma AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Heidelberg Pharma AG has total debt of 36.8m EUR. This includes both short-term (0 EUR) and long-term (36.8m EUR) debt.
You can find a full breakdown on its Balance Sheet.
